Baseimmune
Baseimmune is a biotech startup founded in 2019 that focuses on generating mutation-proof vaccines using a proprietary AI platform. The company combines scientific expertise with advanced computational approaches to design vaccines that maintain efficacy against evolving pathogens. Their early-stage pipeline includes human vaccines for Malaria and a pancoronavirus vaccine, as well as a veterinary vaccine for African Swine Fever. Backed by a strong team with experience from the Jenner Institute at the University of Oxford, Baseimmune aims to revolutionize vaccine development by enabling broader coverage and longer-lasting immunity against complex infectious diseases.
Baseimmune
Baseimmune is a biotech startup founded in 2019 that focuses on generating mutation-proof vaccines using a proprietary AI platform. The company combines scientific expertise with advanced computational approaches to design vaccines that maintain efficacy against evolving pathogens. Their early-stage pipeline includes human vaccines for Malaria and a pancoronavirus vaccine, as well as a veterinary vaccine for African Swine Fever. Backed by a strong team with experience from the Jenner Institute at the University of Oxford, Baseimmune aims to revolutionize vaccine development by enabling broader coverage and longer-lasting immunity against complex infectious diseases.